Novo Nordisk A/S (NVO) ROA - Return on Assets
Current and historical Return on Equity (ROE) values for Novo Nordisk A/S (NVO) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$140.352B||$15.976B|
|Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.|